Nephros (NEPH) EBITDA Margin (2010 - 2026)
Nephros (NEPH) recorded quarterly EBITDA Margin of 1.86% in Q1 2026, up 388.95% quarter-over-quarter from 0.38% in Q4 2025, and down 974.0% on a YoY basis from 0.21% in Q1 2025.
Nephros (NEPH) EBITDA Margin (2010 - 2026) Analysis & Trends
Nephros' EBITDA Margin history runs 17 years deep, the most recent figure standing at 1.86% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 974.0% year-over-year to 1.86%; the TTM figure through Mar 2026 stood at 3.54% (down 144.0% YoY), while the FY2025 annual figure was 6.1%, up 606.0% from the prior year.
- EBITDA Margin was 1.86% for Q1 2026 at Nephros, up from 0.38% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 11.61% in Q1 2025 to a low of 134.12% in Q3 2022.
- Historically, EBITDA Margin has averaged 18.41% across 5 years, with a median of 4.86% in 2023.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 8657 bps in 2022, then surged 12926 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 25.53% in 2022, then grew by 21 bps to 20.1% in 2023, then surged by 141 bps to 8.19% in 2024, then slumped by 95 bps to 0.38% in 2025, then surged by 389 bps to 1.86% in 2026.
- The last three EBITDA Margin figures came in at 1.86% (Q1 2026), 0.38% (Q4 2025), and 6.59% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 1.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86% |
| Dec 31, 2025 | 0.38% |
| Sep 30, 2025 | 6.59% |
| Jun 30, 2025 | 5.61% |
| Mar 31, 2025 | 11.61% |
| Dec 31, 2024 | 8.19% |
| Sep 30, 2024 | 5.86% |
| Jun 30, 2024 | -9.75% |
| Mar 31, 2024 | -4.80% |
| Dec 31, 2023 | -20.10% |
| Sep 30, 2023 | -4.86% |
| Jun 30, 2023 | -12.21% |
| Mar 31, 2023 | -8.28% |
| Dec 31, 2022 | -25.53% |
| Sep 30, 2022 | -134.12% |
| Jun 30, 2022 | -42.21% |
| Mar 31, 2022 | -91.25% |
| Dec 31, 2021 | -38.48% |
| Sep 30, 2021 | -47.56% |
| Jun 30, 2021 | -49.60% |